Litcius/Paper detail

Fusobacterium nucleatum enhances cholesterol biosynthesis in colorectal cancer via miR-130a-3p-mediated AMPK inhibition, a process counteracted by butyrate

Yuting Sun, Jiawei Lu, Effie Yin Tung Lau, Yao Zeng, Shaohua Li, Tina Au, Silin Ye, Tingyu Zhou, Francis K.L. Chan, Qiaoyi Liang

2025Cancer Letters9 citationsDOI

Topics & Concepts

Fusobacterium nucleatumButyrateColorectal cancerAMPKCancer researchFusobacteriumCholesterolBiosynthesisChemistryMicrobiologyBiochemistryInternal medicineCancerBiologyMedicineEnzymeBacteriaBacteroidesGeneticsProtein kinase AFermentationPorphyromonas gingivalisPeriodontitisCancer, Lipids, and MetabolismMetabolism, Diabetes, and CancerGut microbiota and health
Fusobacterium nucleatum enhances cholesterol biosynthesis in colorectal cancer via miR-130a-3p-mediated AMPK inhibition, a process counteracted by butyrate | Litcius